Talecris Biotherapeutics

  Home About Talecris Therapeutic Areas Research & Development Donor to Patient Business Development Investor Relations Media Center  
Media Center Overview
Press Releases
Press Releases Archive
News Features
The History of Talecris
Talecris Leadership
Talecris Media Contact Information

Press Releases

Talecris Biotherapeutics Donates Vital Medical Treatment and Supplies to Haitian Relief Efforts



Research Triangle Park, N.C – (Feb. 15, 2009) -- Talecris Biotherapeutics (Nasdaq: TLCR) has donated life-saving therapy and other supplies to the relief efforts for the victims of the catastrophic earthquake in Haiti.

Talecris has donated more than $100,000 of tetanus immune globulin (human) for prophylaxis against tetanus, a potentially life-threatening disease. This donation was provided through the Crudem Foundation, a charitable organization that runs a hospital, medical clinics, a blood bank and other healthcare programs in Haiti.

In addition to its product donation, Talecris employees have partnered with AmeriCares to provide supplies and financial assistance to the relief efforts, including food items, blankets and sheets, and thousands of dollars in monetary donations.

About Talecris Biotherapeutics: Inspiration. Dedication. Innovation.
Talecris Biotherapeutics is a global biotherapeutic and biotechnology company that discovers, develops and produces critical care treatments for people with life-threatening disorders in a variety of therapeutic areas including immunology, pulmonology, neurology and hemostasis. For more information, please visit: http://www.talecris.com/.

Contact:
Talecris Corporate Communications
Becky Levine, 919-316-6590
becky.levine@talecris.com

 

 

Print This Page
E-mail This Page
News & Events
See how Talecris is being recognized for innovation and commitment.
Learn More

Talecris Biotherapeutics
Contact Talecris    Glossary    Site Map
General Conditions of Use    Privacy Statement    California Compliance
© 2009 Talecris Biotherapeutics